Suffolk Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $367K | Sell |
|
|||||
|
2018
Q3 | $948K | Sell |
|
|||||
|
2018
Q2 | $892K | Sell |
|
|||||
|
2018
Q1 | $770K | Sell |
|
|||||
|
2017
Q4 | $1.13M | Buy |
|
|||||
|
2017
Q3 | $800K | Sell |
|
|||||
|
2017
Q2 | $1.66M | Buy |
|
|||||
|
2017
Q1 | $1.25M | Sell |
|
|||||
|
2016
Q4 | $1.31M | Sell |
|
|||||
|
2016
Q3 | $1.59M | Sell |
|
|||||
|
2016
Q2 | $2.44M | Buy |
|
|||||
|
2016
Q1 | $1.56M | Sell |
|
|||||
|
2015
Q4 | $2.34M | Sell |
|
|||||
|
2015
Q3 | $2.42M | Buy |
|
|||||
|
2015
Q2 | $2.48M | Sell |
|
|||||
|
2015
Q1 | $3.28M | Sell |
|
|||||
|
2014
Q4 | $2.85M | Buy |
|
|||||
|
2014
Q3 | $1.56M | Sell |
|
|||||
|
2014
Q2 | $2.7M | Buy |
|
|||||
|
2014
Q1 | $1.85M | Buy |
|